Dupixent and Rashes - a phase IV clinical study of FDA data
Summary:
Rashes is found among people who take Dupixent, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Dupixent and have Rashes. It is created by eHealthMe based on reports of 125,036 people who have side effects when taking Dupixent from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
125,036 people reported to have side effects when taking Dupixent.
Among them, 14,713 people (11.77%) have Rashes.
What is Dupixent?
Dupixent has active ingredients of dupilumab. eHealthMe is studying from 125,101 Dupixent users for its effectiveness, alternative drugs and more.
What is Rashes?
Rashes (redness) is found to be associated with 5,130 drugs and 6,028 conditions by eHealthMe.
Number of Dupixent and Rashes reports submitted per year:
Time on Dupixent when people have Rashes *:
Gender of people who have Rashes when taking Dupixent*:
Age of people who have Rashes when taking Dupixent *:
Common drugs people take besides Dupixent *:
Common side effects people have besides Rashes *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Dupixent and have Rashes?
Check whether Rashes is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Rashes and when was it recovered:
Expand to all the drugs that have ingredients of dupilumab:
- Rashes and drugs with ingredients of dupilumab (9,862 reports)
Alternative drugs to, pros and cons of Dupixent:
- Dupixent (125,101 reports)
Common Dupixent side effects:
- Rashes (redness): 14,713 reports
- Itching: 11,478 reports
- Drug ineffective: 7,446 reports
- Dry skin: 4,984 reports
- Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 4,733 reports
- Dry eyes (lack of adequate tears): 3,864 reports
- Joint pain: 3,702 reports
Browse all side effects of Dupixent:
a b c d e f g h i j k l m n o p q r s t u v w x y zRashes treatments and more:
- Rashes (603,842 reports)
COVID vaccines that are related to Rashes:
- Rashes in Moderna COVID Vaccine
- Rashes in Pfizer BioNTech Covid Vaccine
- Rashes in Johnson and Johnson Covid Vaccine
Common drugs associated with Rashes:
- Adapalene: 49,040 reports
- Humira: 32,791 reports
- Prednisone: 31,608 reports
- Methotrexate: 30,738 reports
- Enbrel: 29,268 reports
- Green tea: 21,666 reports
- Aspirin: 20,315 reports
- Revlimid: 15,559 reports
- Dupixent: 14,713 reports
- Orencia: 13,951 reports
All the drugs that are associated with Rashes:
- Rashes (5,130 drugs)
Common conditions associated with Rashes:
- Rheumatoid arthritis: 43,808 reports
- Acne: 29,888 reports
- High blood pressure: 18,830 reports
- Multiple sclerosis: 17,182 reports
- Multiple myeloma: 16,635 reports
All the conditions that are associated with Rashes:
- Rashes (6,028 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on dupilumab (the active ingredients of Dupixent) and Dupixent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cyclosporine and Complex Regional Pain Syndrome - now
- Theophylline and Hyponatraemia Aggravated - 3 seconds ago
- Phoslyra and Calcitriol drug interaction - 9 seconds ago
- Luvox and White Blood Cell Disorder - 11 seconds ago
- Sitagliptin Phosphate and Hydrocortisone drug interaction - 27 seconds ago
- Oxycodone And Acetaminophen and Appetite - Decreased - 38 seconds ago
- Oxycodone And Acetaminophen and Appetite Decreased - 38 seconds ago
- Accolate and Guillain-Barre Syndrome - 47 seconds ago
- Accolate and Guillain Barre Syndrome - 47 seconds ago
- Accolate and Guillain-Barré Syndrome - 47 seconds ago